在晚期乳腺癌中使用 ribociclib 的初始实践经验
Azhar Nawaz1,2, Jamal Zekri1,3,4, Haleem Rasool1,5
1King Faisal Specialist Hospital & Research Centre (Jeddah), Jeddah, Saudi Arabia.
概括
与激素治疗相结合的利博西克利布在晚期乳腺癌患者中显示出强烈的无进展生存率 (PFS) 和整体生存率 (OS). 然而,不良事件导致停药率高于临床试验.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
背景情况:
- 像 ribociclib 这样的 CDK4/6 抑制剂是高级激素受体阳性,HER2 阴性乳腺癌的标准.
- 与荷尔蒙疗法的结合是推的治疗方法.
研究的目的:
- 为了评估 ribociclib 的现实有效性.
- 为了评估我们机构的乳腺癌患者里博西基利布的安全性和耐受性.
主要方法:
- 68名接受 > 1 个周期的 ribociclib 的患者的回顾性分析 (2018 年 12 月至 2022 年 3 月).
- 通过不良事件 (AEs),剂量减少和停药率来评估不耐受性.
主要成果:
- 无进展生存时间 (PFS) 的中位数为18个月;84%的人在3年后还活着 (总生存时间 (OS) 的中位数未达到).
- 副作用导致44%的患者减少剂量,13.2%的患者终止治疗.
- 可评估患者的客观应答率为16.4%.
结论:
- 利博西克利布与莱特醇或富尔韦斯特兰特在现实环境中显示出显著的PFS和OS.
- 与临床试验相比,由于副作用而中止治疗的比率更高.
- 在重度预治疗的患者中,观察到适度的客观反应率.
相关概念视频
Treatment Resistant Cancers
3.2K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.2K
Clinical Trials
6.6K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.6K
Clinical Trials: Overview
2.7K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.7K
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Cancer Vaccines
327
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
327


